DE69716741T2 - Pharmazeutische zusammensetzung, enthaltend serum-amyloid p-komponenten, zur prophylaxe und therapie von viralen infektionen sowie kit zur detektionvon komplexen zwischen solchen zusammensetzungen und viralen komponenten - Google Patents

Pharmazeutische zusammensetzung, enthaltend serum-amyloid p-komponenten, zur prophylaxe und therapie von viralen infektionen sowie kit zur detektionvon komplexen zwischen solchen zusammensetzungen und viralen komponenten

Info

Publication number
DE69716741T2
DE69716741T2 DE69716741T DE69716741T DE69716741T2 DE 69716741 T2 DE69716741 T2 DE 69716741T2 DE 69716741 T DE69716741 T DE 69716741T DE 69716741 T DE69716741 T DE 69716741T DE 69716741 T2 DE69716741 T2 DE 69716741T2
Authority
DE
Germany
Prior art keywords
components
viral
amyloid
prophylaxis
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69716741T
Other languages
English (en)
Other versions
DE69716741D1 (de
Inventor
Sven-Erik Svehag
Ellen Holm Nielsen
Ove Andersen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PROFYLAKSE APS ODENSE
Original Assignee
PROFYLAKSE APS ODENSE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PROFYLAKSE APS ODENSE filed Critical PROFYLAKSE APS ODENSE
Application granted granted Critical
Publication of DE69716741D1 publication Critical patent/DE69716741D1/de
Publication of DE69716741T2 publication Critical patent/DE69716741T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DE69716741T 1996-01-25 1997-01-24 Pharmazeutische zusammensetzung, enthaltend serum-amyloid p-komponenten, zur prophylaxe und therapie von viralen infektionen sowie kit zur detektionvon komplexen zwischen solchen zusammensetzungen und viralen komponenten Expired - Fee Related DE69716741T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK7996 1996-01-25
PCT/DK1997/000035 WO1997026906A1 (en) 1996-01-25 1997-01-24 Pharmaceutical composition comprising serum amyloid p component for prophylactic or therapeutic treatment of virus infections and a kit for detecting binding of compositions to virus components

Publications (2)

Publication Number Publication Date
DE69716741D1 DE69716741D1 (de) 2002-12-05
DE69716741T2 true DE69716741T2 (de) 2003-06-12

Family

ID=8089501

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69716741T Expired - Fee Related DE69716741T2 (de) 1996-01-25 1997-01-24 Pharmazeutische zusammensetzung, enthaltend serum-amyloid p-komponenten, zur prophylaxe und therapie von viralen infektionen sowie kit zur detektionvon komplexen zwischen solchen zusammensetzungen und viralen komponenten

Country Status (10)

Country Link
US (1) US6406698B1 (de)
EP (1) EP0915707B1 (de)
AT (1) ATE226829T1 (de)
AU (1) AU712819B2 (de)
CA (1) CA2247388C (de)
DE (1) DE69716741T2 (de)
DK (1) DK0915707T3 (de)
ES (1) ES2185900T3 (de)
PT (1) PT915707E (de)
WO (1) WO1997026906A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4575897A (en) * 1996-10-11 1998-05-11 Universiteit Utrecht Pharmaceutical and diagnostic use of serum amyloid p component
US6365570B1 (en) * 1997-10-10 2002-04-02 Universiteit Utrecht Pharmaceutical and diagnostic use of Serum Amyloid P component
CN1301745A (zh) * 1999-12-27 2001-07-04 上海博德基因开发有限公司 一种新的多肽——淀粉样糖蛋白10和编码这种多肽的多核苷酸
US6872541B2 (en) * 2001-07-25 2005-03-29 Coulter International Corp. Method and compositions for analysis of pentraxin receptors as indicators of disease
US20040091503A1 (en) * 2002-08-20 2004-05-13 Genitrix, Llc Lectin compositions and methods for modulating an immune response to an antigen
US20100297074A1 (en) * 2002-12-23 2010-11-25 Richard Hans Gomer Wound healing compositions, systems, and methods
US7763256B2 (en) 2002-12-23 2010-07-27 William Marsh Rice University Compositions and methods for suppressing fibrocytes and for detecting fibrocyte differentiation
US7935682B2 (en) 2002-12-23 2011-05-03 William Marsh Rice University Wound healing dressing for enhancing fibrocyte formation
US8012472B2 (en) 2002-12-23 2011-09-06 William Marsh Rice University Compositions and methods for suppressing fibrocytes
ES2409756T3 (es) 2006-12-04 2013-06-27 Promedior, Inc. Combinación de SAP y de enalapril para su uso en tratamiento de trastornos fibróticos o fibroproliferativos
US7592695B2 (en) * 2006-12-11 2009-09-22 Graftech International Holdings Inc. Compound heat sink
US9884899B2 (en) 2007-07-06 2018-02-06 Promedior, Inc. Methods for treating fibrosis using CRP antagonists
US8497243B2 (en) 2007-07-06 2013-07-30 Promedior, Inc. Methods and compositions useful in the treatment of mucositis
PT2405929T (pt) 2009-03-11 2018-07-23 Promedior Inc Métodos de tratamento para distúrbios autoimunes
AU2010224170B2 (en) 2009-03-11 2015-12-24 Promedior, Inc. Treatment and diagnostic methods for hypersensitive disorders
AU2010232591A1 (en) * 2009-04-01 2011-11-03 Promedior, Inc. Pulmonary and nasal delivery of serum amyloid P
TW201103972A (en) 2009-04-01 2011-02-01 Solvay Fluor Gmbh Process for the manufacture of etched items
UA110323C2 (en) 2009-06-04 2015-12-25 Promedior Inc Derivative of serum amyloid p and their receipt and application
DK2443144T3 (en) 2009-06-17 2015-11-23 Promedior Inc SAP variants and their application
US10295539B2 (en) * 2010-04-19 2019-05-21 Meso Scale Technologies, Llc. Serology assays

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5221628A (en) * 1991-03-19 1993-06-22 Northwestern University Binding of aggregated immunoglobulin or immune complexes by serum amyloid P component
US5270052A (en) * 1991-04-19 1993-12-14 New England Medical Center Hospitals, Inc. Methods and compositions for treatment of infection by intracellular parasites
EP0616535B1 (de) * 1991-11-27 2000-02-02 Immtech International Incorporated Methode zur behandlung von viralen infektionen
DK17093D0 (da) * 1993-02-15 1993-02-15 Lyfjathroun H F Farmaceutisk praeparat til topisk administrering af antigener og/eller vacciner til pattedyr via slimhinder
AU4575897A (en) * 1996-10-11 1998-05-11 Universiteit Utrecht Pharmaceutical and diagnostic use of serum amyloid p component
US5908825A (en) * 1997-01-09 1999-06-01 University Of Maryland At Baltimore Dosage composition for nasal delivery and method of use of the same

Also Published As

Publication number Publication date
WO1997026906A1 (en) 1997-07-31
DK0915707T3 (da) 2003-03-03
PT915707E (pt) 2003-03-31
AU1438097A (en) 1997-08-20
ES2185900T3 (es) 2003-05-01
EP0915707B1 (de) 2002-10-30
ATE226829T1 (de) 2002-11-15
CA2247388A1 (en) 1997-07-31
DE69716741D1 (de) 2002-12-05
US6406698B1 (en) 2002-06-18
AU712819B2 (en) 1999-11-18
EP0915707A1 (de) 1999-05-19
CA2247388C (en) 2009-06-02

Similar Documents

Publication Publication Date Title
DE69716741T2 (de) Pharmazeutische zusammensetzung, enthaltend serum-amyloid p-komponenten, zur prophylaxe und therapie von viralen infektionen sowie kit zur detektionvon komplexen zwischen solchen zusammensetzungen und viralen komponenten
PT83434B (pt) Processo de preparacao de virus recombinantes, de peptidos ou proteinas e de vacinas contra o sindroma de imunodeficiencia adquirida
WO2001068116A3 (en) Immunostimulatory polynucleotide sequences for use in preventing and treating respiratory viral infections
ATE380037T1 (de) Verfaheren zur durch rekombinante adeno- assoziierte virus-gerichtete gentherapie
MY107843A (en) Anti-viral compounds.
DE69818707D1 (de) Chitosan und influenza-antigen(e) enthaltende impfstoff-zubereitungen zur verabreichung durch eine mukosa
UA66744C2 (en) 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections
ES2150496T3 (es) Cicloalquilimidazopiridinas condensadas.
AU3475097A (en) Substituted cyclopentane compounds useful as neuraminidase inhibitors
EP0270317A3 (de) Pharmaceutische Zuberatung zur Behandlung von Virus-Krankheiten
EP0652011A4 (de) Prophylaktisches mittel und arzneimittel für virale erkrankungen der atemwege.
TW200509961A (en) Uses of interferons for the treatment of severe acute respiratory syndrome and other viral infections
ATE89735T1 (de) Pharmazeutische zubereitung zur behandlung von viruskrankheiten mit leber-extrakt.
BR9809234A (pt) Composto, composição farmacêutica, uso de um composto, processos para tratar ou prevenir doenças do sistema endocrinológico, para fabricar um medicamento, para preparar um composto e um conjunto, conjunto, e, uso do mesmo.
ATE220912T1 (de) Herstellung von st1435 enthaltenden pharmazeutischen zusammensetzungen zur topischen verwendung
BR9916893A (pt) Tratamento
EA199800526A1 (ru) Производные бензимидазола и их применение для лечения вирусных инфекций
AU6383296A (en) Multivalent bovine coronavirus vaccine and method of treating bovine coronavirus infection
BR9706938A (pt) Composto uso do mesmo formulação farmacêutica e processos para produzir o composto e para o tratamento ou a prevenção de sintomas ou efeitos de uma infecção virótica em um mamífero infectado incluindo um humano
DK0653939T3 (da) Anvendelse af en Hymenoptera-gift til fremstilling af et medikament til behandling af DNA-virusinfektioner
RU95109909A (ru) Способ ингибирования ретровирусной инфекции, ингибитор протеазы, кодирующая его нуклеиновая кислота и способ рекомбинантного продуцирования серинового ингибитора
KR970701561A (ko) 신규 기도부 바이러스 질환 치료제(Novel Remedy for Respiratory-Tract Viral Disease)
WO2004006848A3 (en) Combination therapies with ftc for the treatment of hepatitis b virus infection
AU2396900A (en) Treatment and prevention of hiv and other viral infections
DE69422980D1 (de) Extrakte von Piliostigma thonningii, deren Verwendung und diese enthaltende Zubereitungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee